| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Norgestrel | FAERS: 48 Canada Vigilance: 2 | Canada Vigilance OFFSIDES US FAERS | |
| 2 | Copper | FAERS: 8 | US FAERS | |
| 3 | Lamotrigine | FAERS: 3 | OFFSIDES US FAERS | |
| 4 | Medroxyprogesterone Acetate | FAERS: 3 | US FAERS | |
| 5 | NuvaRing | FAERS: 3 | US FAERS | |
| 6 | Atorvastatin | FAERS: 1 | US FAERS | |
| 7 | Estradiol | FAERS: 1 | US FAERS | |
| 8 | Estrogens, Conjugated (USP) | FAERS: 1 | US FAERS | |
| 9 | Gefitinib | FAERS: 1 | US FAERS | |
| 10 | Leuprolide | FAERS: 1 | US FAERS | |
| 11 | Ospemifene | FAERS: 1 | US FAERS | |
| 12 | Raloxifene Hydrochloride | FAERS: 1 | US FAERS | |
| 13 | rofecoxib | FAERS: 1 | US FAERS | |
| 14 | Lasofoxifene | SIDER | ||
| 15 | Nabumetone | OFFSIDES | ||
| 16 | Progesterone | OFFSIDES | ||
| 17 | Tamoxifen | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.